Moreover, our in vitro results, together with previous literature (Ganti et al., 2006), prove that the ERα expressed in lung cancer cells can respond to E2 activation, which provides further evidence that the ERα in lung cancer cells functions well. Here, ESR1 is linked to lung carcinoma.